Table 1. Airway fluid sampling.
Approach | Volume recovered | Protein concentration and/or type | Limitations of approach |
---|---|---|---|
Bronchoalveolar lavage | 50–100 ml | 0.05–1.5 μg/pL Plasma proteins abundant in the presence of airway inflammation |
Method is invasive; primarily for research application No consensus for recovery control or normalization |
Induced sputum | 0.5–3.0 ml of sputum + saline | Sample is mucous-rich, which may interfere with downstream analysis | Method samples proximal airway fluid; contamination with saliva can interfere with airway sampling |
Nasopharyngeal aspirate | Protocol dependent | Mucous rich | Samples upper respiratory tract- regional |
EBC | 1 ml/5–15 min collection | No cells are obtained Cytokines IL-8, IL-1b, TNF, IL-10 detectable Gases and metabolites |
Dilution controls needed Samples airway lining fluids and proteins, no cells recovered |
Plasma | 10–100 ml | Wide dynamic range in the milligram per milliliter range, requires depletion approaches | Not fully representative of airway proteins Large dynamic range of proteins complicates analysis |